• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

VanEck Biotech ETF (NQ:BBH)

240.47 +6.43 (+2.75%)
Official Closing Price Updated: 4:15 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,885
Open 234.08
Bid (Size) 240.27 (100)
Ask (Size) 240.53 (100)
Prev. Close 234.03
Today's Range 234.08 - 240.47
52wk Range 171.63 - 246.55
Shares Outstanding N/A
Dividend Yield 0.40%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH ↗
October 10, 2026
VanEck's lower 0.35% expense ratio appeals to cost-conscious investors, while First Trust's $2.9 billion in assets and equal-weighted approach offer broader diversification across 30 biotech holdings. 
Via The Motley Fool
Topics ETFs
News headline image
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma ↗
October 10, 2026
BBH concentrates on 25 large-cap biotech leaders, while XPH diversifies across 62 pharmaceutical holdings. Both charge 0.35% annually, but their five-year returns diverged significantly. 
Via The Motley Fool
Topics ETFs

Performance

52-Week Range 2.5% below 52-week high
240.47
171.6352W Low 246.5552W High
1 Week 1.3% below 1-week high
230.251W Low 243.691W High

VanEck Biotech ETF (BBH) traded between $171.63 and $246.55 over the past 52 weeks and last traded at $240.47, 2.5% below its 52-week high. Over the past week it ranged between $230.25 and $243.69.

Past 12 Months
-0.0%
+5.2%
+17.6%
+26.4%
+26.4%
+39.7%
1W -$0.06
1M +$11.83
3M +$36.01
6M +$50.19
YTD +$50.24
1Y +$68.38

BBH was +39.7% over the past year, +26.4% over six months, +26.4% year to date, -0.0% in the last week.

12 Months vs Market
BBH
+39.7%
DIA
+13.5%
SPY
+19.2%
QQQ
+27.4%
IWM
+17.3%

Over the past 12 months BBH returned +39.7% versus DIA (Dow) +13.5%, SPY (S&P 500) +19.2%, QQQ (Nasdaq 100) +27.4% and IWM (Russell 2000) +17.3%.

Volume & Liquidity 1.18× 3-mo avg
Today 10,885 3-mo avg 9.2K
1W
12.1K
1M
9.8K
3M
9.2K
6M
7.3K
YTD
7.1K
1Y
7.4K

BBH most recently traded 10,885 shares against a 3-month average daily volume of 9.2K.

More News

Read More
News headline image
Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy? ↗
September 24, 2026
Via The Motley Fool
Topics ETFs
PLRZ Stock Jumps 6% In Pre-Market – Why Is This Biotech Firm Diversifying Into Aviation Business? ↗
February 10, 2026
Via Stocktwits
News headline image
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? ↗
September 15, 2026
Via The Motley Fool
Topics ETFs
News headline image
Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals? ↗
August 28, 2026
Via The Motley Fool
Topics ETFs
News headline image
Which Biotech ETF Is a Better Buy: Concentrated Bet or Broad Basket? ↗
August 22, 2026
Via The Motley Fool
Topics ETFs
News headline image
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech? ↗
August 20, 2026
Via The Motley Fool
Topics ETFs
News headline image
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026? ↗
August 05, 2026
Via The Motley Fool
Topics ETFs
News headline image
Vanguard Health Care ETF Outperforms VanEck Biotech on Returns, Yield, and Fees ↗
July 28, 2026
Via The Motley Fool
Topics ETFs
News headline image
iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026? ↗
July 23, 2026
Via The Motley Fool
Topics ETFs
News headline image
IHE vs. BBH: Which Healthcare ETF Is the Better Buy Right Now? ↗
July 19, 2026
Via The Motley Fool
Topics ETFs
News headline image
Invesco Healthcare ETF vs VanEck Biotech: Which ETF Will Deliver the Healthiest Returns for 2026? ↗
July 14, 2026
Via The Motley Fool
Topics ETFs
News headline image
Which is the Better Choice for Healthcare Investors? IYH or BBH? ↗
July 11, 2026
Via The Motley Fool
Topics ETFs
News headline image
BBH vs. XPH: Which Healthcare ETF Is Better for Beginners? ↗
July 08, 2026
Via The Motley Fool
Topics ETFs
News headline image
FHLC vs. BBH: Which Healthcare ETF Is the Better Buy? ↗
July 04, 2026
Via The Motley Fool
Topics ETFs
News headline image
Regeneron’s New Growth Engine Is Starting To Show – But Core Eylea Weakness Weighs On REGN Stock ↗
January 30, 2026
Via Stocktwits
News headline image
VanEck Announces Year-End Distributions for VanEck Equity ETFs
December 19, 2025
From VanEck
Via Business Wire
News headline image
VanEck Announces Year-End Distributions for VanEck Equity ETFs
December 20, 2024
From VanEck
Via Business Wire
News headline image
VanEck Announces Year-End Distributions for VanEck Equity ETFs
December 15, 2023
From VanEck
Via Business Wire
News headline image
Time For Gilead Sciences-Heavy ETFs? ↗
September 12, 2023
Via Talk Markets
News headline image
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention ↗
April 13, 2023
Via Benzinga
News headline image
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules ↗
April 13, 2023
Via Benzinga
News headline image
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications ↗
April 12, 2023
Via Benzinga
News headline image
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead ↗
April 11, 2023
Via Benzinga

Frequently Asked Questions

Is VanEck Biotech ETF publicly traded?
Yes, VanEck Biotech ETF is publicly traded.
What exchange does VanEck Biotech ETF trade on?
VanEck Biotech ETF trades on the Nasdaq Stock Market
What is the ticker symbol for VanEck Biotech ETF?
The ticker symbol for VanEck Biotech ETF is BBH on the Nasdaq Stock Market
What is the current price of VanEck Biotech ETF?
The current price of VanEck Biotech ETF is 240.47
When was VanEck Biotech ETF last traded?
The last trade of VanEck Biotech ETF was at 10/09/26 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap